title: RNAi-mediated inhibition of MSP58 decreases tumour growth, migration and invasion in a human glioma cell line.
abstract: MSP58, a 58-kD nuclear microspherule protein, is an evolutionarily conserved nuclear protein implicated in the regulation of gene transcription as well as in malignant transformation. An analysis of mRNA expression by real-time PCR revealed that MSP58 was significantly up-regulated in 29% of high-grade glioblastoma tissues as well as in four glioblastoma cell lines. In the present study, we further evaluated the biological functions of MSP58 in U251 glioma cell proliferation, migration, invasion and tumour growth in vivo by specific MSP58 knockdown using short hairpin RNA (shRNA). We found that MSP58 depletion inhibited glioma cell growth, primarily by inducing cell cycle arrest rather than apoptosis. MSP58 depletion also decreased the invasive capability of glioma cells and anchorage-independent colony formation in soft agar. Moreover, suppression of MSP58 expression significantly impaired the growth of glioma xenografts in nude mice. Finally, a cell cycle-associated gene array revealed potential molecular mechanisms contributing to cell cycle arrest in MSP58-depleted glioma cells. In summary, our data highlight the importance of MSP58 in glioma progression and provided a biological basis for MSP58 as a novel candidate target for treatment of glioma.
authors.affiliation: Department of Biochemistry and Molecular Biology, The Fourth Military Medical University and The State Key Laboratory of Cancer Biology, Xi'an, The People's Republic of China.
authors.forename: Wei
authors.initials: W
authors.lastname: Lin
authors.forename: Jing
authors.initials: J
authors.lastname: Zhang
authors.forename: Jian
authors.initials: J
authors.lastname: Zhang
authors.forename: Xinping
authors.initials: X
authors.lastname: Liu
authors.forename: Zhou
authors.initials: Z
authors.lastname: Fei
authors.forename: Xia
authors.initials: X
authors.lastname: Li
authors.forename: Laetitia
authors.initials: L
authors.lastname: Davidovic
authors.forename: Zhuo
authors.initials: Z
authors.lastname: Tang
authors.forename: Lan
authors.initials: L
authors.lastname: Shen
authors.forename: Yanchun
authors.initials: Y
authors.lastname: Deng
authors.forename: Angang
authors.initials: A
authors.lastname: Yang
authors.forename: Hua
authors.initials: H
authors.lastname: Han
authors.forename: Xiang
authors.initials: X
authors.lastname: Zhang
authors.forename: Libo
authors.initials: L
authors.lastname: Yao
mesh_terms: D000818:Animals; D002448:Cell Adhesion; D002453:Cell Cycle / Q000235:genetics; D045744:Cell Line, Tumor; D002465:Cell Movement; D049109:Cell Proliferation; D015536:Down-Regulation / Q000235:genetics; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D055785:Gene Knockdown Techniques; D005910:Glioma / Q000235:genetics / Q000473:pathology*; D006801:Humans; D051379:Mice; D008807:Mice, Inbred BALB C; D009361:Neoplasm Invasiveness; D009687:Nuclear Proteins / Q000235:genetics / Q000378:metabolism*; D034622:RNA Interference; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D034741:RNA, Small Interfering / Q000378:metabolism; D016601:RNA-Binding Proteins / Q000235:genetics / Q000378:metabolism*; D014410:Tumor Stem Cell Assay
chemical_list: C113292:MCRS1 protein, human; D009687:Nuclear Proteins; D012333:RNA, Messenger; D034741:RNA, Small Interfering; D016601:RNA-Binding Proteins
references.citation: Oncogene. 2006 Aug 10;25(35):4937-46
references.pmid: 16547491
references.citation: Cancer. 2004 Nov 15;101(10):2293-9
references.pmid: 15476282
references.citation: Mol Cell. 2002 May;9(5):931-43
references.pmid: 12049731
references.citation: Mol Cell Biol. 2001 Jul;21(13):4246-55
references.pmid: 11390653
references.citation: Drugs. 1997 Feb;53(2):235-44
references.pmid: 9028743
references.citation: J Cell Biol. 1999 Jan 25;144(2):373-84
references.pmid: 9922462
references.citation: Cancer Res. 2001 Sep 15;61(18):6693-7
references.pmid: 11559537
references.citation: Cell. 2006 Jul 28;126(2):231-5
references.pmid: 16873051
references.citation: Methods Mol Med. 2005;106:11-34
references.pmid: 15375310
references.citation: Med Oncol. 2007;24(2):231-8
references.pmid: 17848749
references.citation: Nature. 1998 Feb 19;391(6669):806-11
references.pmid: 9486653
references.citation: J Biol Chem. 2005 Nov 25;280(47):39436-47
references.pmid: 16186106
references.citation: Hum Gene Ther. 2002 Mar 1;13(4):497-508
references.pmid: 11874628
references.citation: Biochem J. 2007 Jun 15;404(3):373-81
references.pmid: 17381424
references.citation: Methods. 2005 Oct;37(2):208-15
references.pmid: 16288884
references.citation: Genes Dev. 2002 Apr 15;16(8):948-58
references.pmid: 11959843
references.citation: Breast J. 2006 Sep-Oct;12(5):470-4
references.pmid: 16958968
references.citation: Biochem Biophys Res Commun. 2007 Jan 5;352(1):6-11
references.pmid: 17109818
references.citation: Exp Cell Res. 2006 Jul 1;312(11):1996-2008
references.pmid: 16630610
references.citation: Nat Cell Biol. 2000 Feb;2(2):70-5
references.pmid: 10655585
references.citation: J Biol Chem. 2005 Jul 1;280(26):25008-21
references.pmid: 15855171
references.citation: Am J Clin Pathol. 2005 Oct;124(4):543-9
references.pmid: 16146813
references.citation: Hum Mol Genet. 2006 May 1;15(9):1525-38
references.pmid: 16571602
references.citation: Clin Cancer Res. 2006 Nov 1;12(21):6331-6
references.pmid: 17085642
references.citation: Carcinogenesis. 2007 Oct;28(10):2207-17
references.pmid: 17510082
references.citation: Nature. 2007 Nov 8;450(7167):309-13
references.pmid: 17994099
references.citation: Nature. 2001 May 24;411(6836):494-8
references.pmid: 11373684
references.citation: Cancer Biol Ther. 2004 Aug;3(8):739-51
references.pmid: 15197348
references.citation: Oncogene. 2001 Nov 8;20(51):7524-35
references.pmid: 11709724
references.citation: Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2703-6
references.pmid: 15659546
references.citation: J Biol Chem. 2002 Jul 12;277(28):25446-56
references.pmid: 11948183
references.citation: Int J Cancer. 2003 Sep 1;106(3):342-7
references.pmid: 12845671
references.citation: Cancer Gene Ther. 2004 Mar;11(3):186-93
references.pmid: 14739938
references.citation: Cancer Res. 1995 Dec 15;55(24):6166-71
references.pmid: 8521409
references.citation: Breast Cancer Res. 2008;10(2):R22
references.pmid: 18328103
references.citation: Brain Tumor Pathol. 2007;24(1):7-13
references.pmid: 18095138
references.citation: Cell Mol Life Sci. 2005 Feb;62(4):471-84
references.pmid: 15719173
references.citation: Science. 2002 Apr 19;296(5567):550-3
references.pmid: 11910072
references.citation: Neurol Med Chir (Tokyo). 2007 Apr;47(4):165-70; discussion 170
references.pmid: 17457020
references.citation: Eur J Biochem. 1998 May 1;253(3):734-42
references.pmid: 9654073
references.citation: Tumour Biol. 2007;28(3):165-72
references.pmid: 17519535
references.citation: Hum Gene Ther. 2000 Jul 1;11(10):1397-406
references.pmid: 10910137